Concepedia

Paul H. Tolerico

PH

Statistics

Publications

5

Citations

652

H-Index

5

Active since

1993

Affiliations

Harvard University(Current)

York General Hospital

Penn State Milton S. Hershey Medical Center

Beth Israel Deaconess Medical Center

Columbia University Irving Medical Center

Paul H. Tolerico is an author at Harvard University specializing in cardiology, interventional cardiology, and medicine.

Publications per year

1993–2018

5

Publications

5

A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial

William A. Gray, Koen Keirse, Yoshimitsu Soga et al. · The Lancet · 2018 · 289 citations

, , +16

Prevalence of Fracture and Fragment Embolization of Bard Retrievable Vena Cava Filters and Clinical Implications Including Cardiac Perforation and Tamponade

William Nicholson, W. J. Nicholson, Paul H. Tolerico et al. · Archives of Internal Medicine · 2010 · 225 citations

, , +12

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

Muthiah Vaduganathan, Robert A. Harrington, Gregg W. Stone et al. · Journal of the American College of Cardiology · 2017 · 57 citations

, , +14

Alterations in levels of Na(+)-K(+)-ATPase isoforms in heart, skeletal muscle, and kidney of diabetic rats

Yuk-Chow Ng, Paul H. Tolerico, C. B. Book · American Journal of Physiology-Endocrinology and Metabolism · 1993 · 45 citations

, , +17

Impact of Drug Eluting Stent Length on Outcomes of Percutaneous Coronary Intervention (from the EVENT Registry)

Ronald Caputo, Ankush Goel, Michael Pencina et al. · The American Journal of Cardiology · 2012 · 36 citations

, , +15

1–5 of 5